Mercuric chloride-induced glomerulopathy in BN-rats: application to preclinical drug testing.
Hermann
P
P
Sandoz, Basel, Switzerland.
Poschmann
G
G
Bolliger
S
S
Meyer
D
D
Schuurman
H J
HJ
D000818:Animals; D001327:Autoimmune Diseases / Q000139:chemically induced* / Q000517:prevention & control; D016572:Cyclosporine / Q000494:pharmacology; D004353:Drug Evaluation, Preclinical; D005260:Female; D005921:Glomerulonephritis / Q000139:chemically induced* / Q000517:prevention & control; D007166:Immunosuppressive Agents / Q000494:pharmacology; D008627:Mercuric Chloride / Q000633:toxicity*; D011090:Polyenes / Q000494:pharmacology; D011507:Proteinuria / Q000139:chemically induced / Q000517:prevention & control; D051381:Rats; D011914:Rats, Inbred BN; D020123:Sirolimus; D013163:Splenomegaly / Q000139:chemically induced / Q000517:prevention & control; D015431:Weight Loss / Q000187:drug effects
D007166:Immunosuppressive Agents; D011090:Polyenes; D008627:Mercuric Chloride; D016572:Cyclosporine; D020123:Sirolimus